CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
| | | |

CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population

On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…